Radiotherapy and radio‐sensitization in H3 (K27M) ‐mutated diffuse midline gliomas

BACKGROUND: H3 (K27M) mutated diffuse midline gliomas (DMGs) are extremely aggressive and the leading cause of cancer‐related deaths in pediatric brain tumors with 5‐year survival <1%. Radiotherapy is the only established adjuvant treatment of H3 (K27M) DMGs; however, the radio‐resistance is comm...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chao, Kuang, Shuwen, Wu, Lei, Cheng, Quan, Gong, Xuan, Wu, Jun, Zhang, Longbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324372/
https://www.ncbi.nlm.nih.gov/pubmed/37157237
http://dx.doi.org/10.1111/cns.14225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324372/
https://www.ncbi.nlm.nih.gov/pubmed/37157237
http://dx.doi.org/10.1111/cns.14225

Ejemplares similares